Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

diagnosis

  • Open Access
    Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
    JAROSLAV JURACEK, MARIE MADRZYK, KAROLINA TRACHTOVA, MICHAELA RUCKOVA, JULIA BOHOSOVA, DOMINIK A. BARTH, MARTIN PICHLER, MICHAL STANIK and ONDREJ SLABY
    Cancer Genomics & Proteomics May 2023, 20 (3) 308-316; DOI: https://doi.org/10.21873/cgp.20383
  • Open Access
    Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin
    IVANA ROSKOVA, MAREK VECERA, LENKA RADOVA, KAROLINA TRACHTOVA, FRANTISEK SIEGL, MARKETA HERMANOVA, MICHAL HENDRYCH, LEOS KREN, VACLAV VYBIHAL, HANA VALEKOVA, PETRA KASPAROVA, IVANA KOLOUSKOVA, TOMAS KAZDA, ONDREJ SLABY, RADIM JANCALEK, JIRI SANA and MARTIN SMRCKA
    Cancer Genomics & Proteomics January 2023, 20 (1) 18-29; DOI: https://doi.org/10.21873/cgp.20361
  • Open Access
    TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
    GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO
    Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
  • Open Access
    Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients
    CHERYLLE GOEBEL, CHRISTOPHER L. LOUDEN, ROBERT MCKENNA, OSITA ONUGHA, ANDREW WACHTEL and THOMAS LONG
    Cancer Genomics & Proteomics July 2019, 16 (4) 229-244; DOI: https://doi.org/10.21873/cgp.20128
  • Open Access
    NOTUM Is Involved in the Progression of Colorectal Cancer
    JONG HYUK YOON, DAYEA KIM, JAEYOON KIM, HYEONGJOO LEE, JAEWANG GHIM, BYUNG JUN KANG, PARKYONG SONG, PANN-GHILL SUH, SUNG HO RYU and TAEHOON G. LEE
    Cancer Genomics & Proteomics November 2018, 15 (6) 485-497; DOI: https://doi.org/10.21873/cgp.20107
  • Open Access
    Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
    PETR KARASEK, NATALIA GABLO, JAN HLAVSA, IGOR KISS, PETRA VYCHYTILOVA-FALTEJSKOVA, MARKETA HERMANOVA, ZDENEK KALA, ONDREJ SLABY and VLADIMIR PROCHAZKA
    Cancer Genomics & Proteomics July 2018, 15 (4) 321-327; DOI: https://doi.org/10.21873/cgp.20090
  • Open Access
    Diagnostic MicroRNA Markers to Screen for Sporadic Human Colon Cancer in Stool: I. Proof of Principle
    FARID E. AHMED, NANCY C. AHMED, PAUL W. VOS, CHRIS BONNERUP, JAMES N. ATKINS, MICHELLE CASEY, GERARD J. NUOVO, WADE NAZIRI, JOHN E. WILEY, HELVECIO MOTA and RON R. ALLISON
    Cancer Genomics & Proteomics May 2013, 10 (3) 93-113;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire